Cecilia Goldenberg
SENIOR DIRECTOR, BUSINESS DEVELOPMENT
10+ years of biopharmaceutical and cell and gene experience, working in business development at PCT, Charles River and Lonza.
About Cecilia
Cecilia Goldenberg brings with her 10+ years of biopharmaceutical and cell and gene experience, during which she held business development positions at PCT, Charles River and Lonza. During that time, she also earned valuable CGT experience in development, manufacturing, and commercialization.
In 2014, she joined PCT, where she focused on the development of the proposal department and focused on driving growth of the clinical and commercial opportunities.
2019, Cecilia joined Lonza’s cell and gene business unit and lead the US with building out a robust pipeline of opportunities for modalities (including technology focus) included in autologous and allogeneic therapies: CD34 cells, CAR-T, MSC, induced pluripotent stem cells (iPSCs) as well as gene therapies such as adeno-associated virus (AAV), and lentiviral vector (LVV).
INDUSTRY EXPERIENCE
Lonza
Director, Business Development
Charles River Labs
Director, Business Development
Hitachi Chemical Advanced Therapeutics Solutions (HCATS)
Associate Director, Business Development
EDUCATION
California State University, Long Beach Bachelor of Arts: Journalism with an emphasis in Public Relations, Spanish